ICON plc (ICLR) Ordinary EUR0.06

Sell:$193.21Buy:$193.69$1.47 (0.75%)

NASDAQ:1.35%
Market closed | Prices delayed by at least 15 minutes
Sell:$193.21
Buy:$193.69
Change:$1.47 (0.75%)
Market closed | Prices delayed by at least 15 minutes
Sell:$193.21
Buy:$193.69
Change:$1.47 (0.75%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Key people

Stephen Cutler
Chief Executive Officer, Director
Brendan Brennan
Chief Financial Officer
Barry Balfe
Chief Operating Officer
Diarmaid Cunningham
Chief Administrative Officer, General Counsel, Company Secretary
Ciaran Murray
Non-Executive Independent Chairman of the Board
Ronan Murphy
Lead Independent Director
Anne C. Whitaker
Non-Executive Director
John Climax
Independent Director
Linda S. Grais
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Ireland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    IE0005711209
  • Market cap
    $16.14bn
  • Employees
    42,250
  • Shares in issue
    82.56m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.